*Medical policy marks a key commercial milestone as one of the nation's largest insurers recognizes the clinical importance of Alzheimer's blood biomarker testing*. C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, a
